Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Reich

Showing results (341-350 of 349) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 349 results.
Journal of Medicinal Chemistry|July 21, 1998
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studiesP S Dragovich, S E Webber, R E Babine, et al.
Journal of Medicinal Chemistry|July 21, 1998
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studiesP S Dragovich, S E Webber, R E Babine, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|June 10, 2015
The current state of facial prosthetics – A multicenter analysisOliver C Thiele, Jörn Brom, Anton Dunsche, et al.
Journal of Medicinal Chemistry|March 13, 2018
Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) InhibitionSiegfried H Reich, Paul A Sprengeler, Gary G Chiang, et al.
Nature Genetics|March 10, 2009
Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24Stefanie Birnbaum, Kerstin U Ludwig, Heiko Reutter, et al.
Molecular Cancer Therapeutics|November 26, 2009
SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivoSean G Buchanan, Jorg Hendle, Patrick S Lee, et al.
Nature Genetics|August 7, 2012
Genome-wide meta-analyses of nonsyndromic cleft lip with or without cleft palate identify six new risk lociKerstin U Ludwig, Elisabeth Mangold, Stefan Herms, et al.
Nature Genetics|December 22, 2009
Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palateElisabeth Mangold, Kerstin U Ludwig, Stefanie Birnbaum, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|March 13, 2018
Current concepts in cleft care: A multicenter analysisOliver C Thiele, Matthias Kreppel, Anton Dunsche, et al.
Pageof 35

Showing results (341-350 of 349) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 349 results.
Journal of Medicinal Chemistry|July 21, 1998
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studiesP S Dragovich, S E Webber, R E Babine, et al.
Journal of Medicinal Chemistry|July 21, 1998
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studiesP S Dragovich, S E Webber, R E Babine, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|June 10, 2015
The current state of facial prosthetics – A multicenter analysisOliver C Thiele, Jörn Brom, Anton Dunsche, et al.
Journal of Medicinal Chemistry|March 13, 2018
Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) InhibitionSiegfried H Reich, Paul A Sprengeler, Gary G Chiang, et al.
Nature Genetics|March 10, 2009
Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24Stefanie Birnbaum, Kerstin U Ludwig, Heiko Reutter, et al.
Molecular Cancer Therapeutics|November 26, 2009
SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivoSean G Buchanan, Jorg Hendle, Patrick S Lee, et al.
Nature Genetics|August 7, 2012
Genome-wide meta-analyses of nonsyndromic cleft lip with or without cleft palate identify six new risk lociKerstin U Ludwig, Elisabeth Mangold, Stefan Herms, et al.
Nature Genetics|December 22, 2009
Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palateElisabeth Mangold, Kerstin U Ludwig, Stefanie Birnbaum, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|March 13, 2018
Current concepts in cleft care: A multicenter analysisOliver C Thiele, Matthias Kreppel, Anton Dunsche, et al.
Pageof 35